Jennifer Hyde

2.6k total citations
43 papers, 1.8k citations indexed

About

Jennifer Hyde is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Jennifer Hyde has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 12 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Jennifer Hyde's work include Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Immunology Research (7 papers) and interferon and immune responses (6 papers). Jennifer Hyde is often cited by papers focused on Viral gastroenteritis research and epidemiology (10 papers), Viral Infections and Immunology Research (7 papers) and interferon and immune responses (6 papers). Jennifer Hyde collaborates with scholars based in United States, Australia and Brazil. Jennifer Hyde's co-authors include Michael Diamond, Michelle R. Arkin, Jason M. Mackenzie, Andrew C. Braisted, Johan D. Oslob, Robert S. McDowell, Warren L. DeLano, Mike Randal, Chul H. Yu and Elizabeth Carter and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jennifer Hyde

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Hyde United States 21 767 542 311 241 196 43 1.8k
Daniel Mayer United States 24 897 1.2× 202 0.4× 642 2.1× 661 2.7× 148 0.8× 53 2.2k
Tetsuya Furuya Japan 31 783 1.0× 576 1.1× 442 1.4× 1.3k 5.2× 209 1.1× 102 3.1k
Hengli Tang United States 34 1.8k 2.4× 1.0k 1.9× 453 1.5× 1.0k 4.3× 240 1.2× 66 3.9k
Joseph G. Joyce United States 26 1.2k 1.5× 539 1.0× 1.0k 3.3× 83 0.3× 31 0.2× 59 3.2k
Holly Ramage United States 15 890 1.2× 708 1.3× 294 0.9× 267 1.1× 87 0.4× 20 1.9k
Linda H.L. Lua Australia 26 989 1.3× 552 1.0× 212 0.7× 118 0.5× 108 0.6× 64 2.1k
Christopher T. Eggers United States 10 2.1k 2.8× 178 0.3× 147 0.5× 92 0.4× 60 0.3× 11 2.7k
Ron Geller Spain 18 803 1.0× 592 1.1× 274 0.9× 171 0.7× 143 0.7× 46 1.6k
Mike Reichelt United States 34 1.4k 1.9× 419 0.8× 737 2.4× 113 0.5× 83 0.4× 66 3.4k

Countries citing papers authored by Jennifer Hyde

Since Specialization
Citations

This map shows the geographic impact of Jennifer Hyde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Hyde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Hyde more than expected).

Fields of papers citing papers by Jennifer Hyde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Hyde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Hyde. The network helps show where Jennifer Hyde may publish in the future.

Co-authorship network of co-authors of Jennifer Hyde

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Hyde. A scholar is included among the top collaborators of Jennifer Hyde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Hyde. Jennifer Hyde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagoner, Jessica, Rana Abdelnabi, Jennifer Hyde, et al.. (2025). Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo. Antiviral Research. 239. 106186–106186.
2.
Schwerk, Johannes, et al.. (2025). Sequence Diversity in the 3′ Untranslated Region of Alphavirus Modulates IFIT2-Dependent Restriction in a Cell Type-Dependent Manner. Journal of Interferon & Cytokine Research. 45(4). 133–149.
3.
Hyde, Jennifer, et al.. (2024). RNA structures within Venezuelan equine encephalitis virus E1 alter macrophage replication fitness and contribute to viral emergence. PLoS Pathogens. 20(9). e1012179–e1012179. 3 indexed citations
4.
Choi, Ryan, et al.. (2023). Regulation of coronavirus nsp15 cleavage specificity by RNA structure. PLoS ONE. 18(8). e0290675–e0290675. 6 indexed citations
5.
Powers, Ann M., Lauren E. Williamson, Robert H. Carnahan, et al.. (2023). Developing a Prototype Pathogen Plan and Research Priorities for the Alphaviruses. The Journal of Infectious Diseases. 228(Supplement_6). S414–S426. 5 indexed citations
6.
Tsu, Brian V., Nandan S. Gokhale, Jessie Kulsuptrakul, et al.. (2023). Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome. PLoS Biology. 21(6). e3002144–e3002144. 26 indexed citations
7.
Deerain, Joshua M., Turgut E. Aktepe, Gregor Ebert, et al.. (2023). Murine norovirus infection of macrophages induces intrinsic apoptosis as the major form of programmed cell death. Virology. 589. 109921–109921. 5 indexed citations
8.
Schwerk, Johannes, Frank Soveg, Kerri R. Thomas, et al.. (2019). RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions. Nature Immunology. 20(12). 1610–1620. 91 indexed citations
9.
10.
Hyde, Jennifer, Rubing Chen, Derek W. Trobaugh, et al.. (2015). The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional. Virus Research. 206. 99–107. 72 indexed citations
11.
Hyde, Jennifer & Michael Diamond. (2015). Innate immune restriction and antagonism of viral RNA lacking 2׳-O methylation. Virology. 479-480. 66–74. 139 indexed citations
12.
Proença‐Módena, José Luiz, Renata Sesti‐Costa, Amelia K. Pinto, et al.. (2015). Oropouche Virus Infection and Pathogenesis Are Restricted by MAVS, IRF-3, IRF-7, and Type I Interferon Signaling Pathways in Nonmyeloid Cells. Journal of Virology. 89(9). 4720–4737. 45 indexed citations
13.
Hyde, Jennifer, Christina L. Gardner, Taishi Kimura, et al.. (2014). A Viral RNA Structural Element Alters Host Recognition of Nonself RNA. Science. 343(6172). 783–787. 130 indexed citations
14.
Hyde, Jennifer, Elizabeth Carter, Sara Kiesler, & Jessica K. Hodgins. (2014). Assessing naturalness and emotional intensity. 15–22. 12 indexed citations
15.
Hyde, Jennifer & Jason M. Mackenzie. (2010). Subcellular localization of the MNV-1 ORF1 proteins and their potential roles in the formation of the MNV-1 replication complex. Virology. 406(1). 138–148. 53 indexed citations
16.
Hyde, Jennifer, et al.. (2006). SNS-032 is a potent and selective inhibitor of CDK2, 7 and 9 and induces cell death by inhibiting cell cycle progression and the expression of antiapoptotic proteins. Cancer Research. 66. 491–491. 7 indexed citations
17.
Hyde, Jennifer, et al.. (2005). The phase I clinical compound SNS-595 acts during S-phase and causes a sustained G2 arrest. Cancer Research. 65. 538–538. 1 indexed citations
18.
Waal, Nathan D., Wenjin Yang, Johan D. Oslob, et al.. (2005). Identification of nonpeptidic small-molecule inhibitors of interleukin-2. Bioorganic & Medicinal Chemistry Letters. 15(4). 983–987. 15 indexed citations
19.
Arkin, Michelle R., Mike Randal, Warren L. DeLano, et al.. (2003). Binding of small molecules to an adaptive protein–protein interface. Proceedings of the National Academy of Sciences. 100(4). 1603–1608. 288 indexed citations
20.
Hyde, Jennifer, Andrew C. Braisted, Mike Randal, & Michelle R. Arkin. (2003). Discovery and Characterization of Cooperative Ligand Binding in the Adaptive Region of Interleukin-2. Biochemistry. 42(21). 6475–6483. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Mayer Breakdown of academic impact, for papers by Tetsuya Furuya Breakdown of academic impact, for papers by Hengli Tang Breakdown of academic impact, for papers by Joseph G. Joyce Breakdown of academic impact, for papers by Holly Ramage Breakdown of academic impact, for papers by Linda H.L. Lua Breakdown of academic impact, for papers by Christopher T. Eggers Breakdown of academic impact, for papers by Ron Geller Breakdown of academic impact, for papers by Mike Reichelt
Rankless by CCL
2026